UNSPSC 51284401: Ceftaroline fosamil

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7P6FQA5D21. European Medicines Agency schedules Ceftaroline fosamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31648. Ceftaroline fosamil generally arises in the molecular formula C22H21N8O8PS4.

The term CEFTAROLINE FOSAMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 1, 2008, list 59.) As of Q4 2014, CEFTAROLINE FOSAMIL remains the US FDA Preferred Term for this commodity. Ceftaroline fosamil bears US NLM identifiers UMLS ID C1873118 and NCI Concept Code C81034. SMILES: CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)O.CC(=O)[O-].O.

UNSPSC 51284401 Ceftaroline fosamil, a Commodity code, shows a significant mismatch between its nominal scope — a specific fourth-generation cephalosporin antibiotic — and recent state and local procurement activity actually being tagged under it. The recent opportunities record includes a Seminole County, Florida IFB for naloxone and drug deactivation systems; a Texas HHS Commission RFI on direct-to-manufacturer prescription programs; a City of Tampa IFB for emergency medical and first aid supplies; and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products. None of these solicitations specifically target ceftaroline fosamil or even narrow-spectrum antibiotics as a line-item commodity. The code displays little relevant recent activity directly aligned with procurement of this antibiotic itself.

The recent opportunities show broader pharmaceutical and medical supply procurement across state health agencies, county health departments, municipal fire departments, and cooperative purchasing consortia. Issuing bodies include the Seminole County community health program, the Texas Health and Human Services Commission, the City of Tampa Fire Department, and MMCAP serving multiple state and local jurisdictions across Minnesota and Oregon. Geographic activity spans Florida, Texas, and the upper Midwest. Response deadlines for active solicitations included March 13, 2026 (Tampa), March 26, 2026 (MMCAP), and July 26, 2023 (Seminole County, noting a date inconsistency in the source). The wide gap between the code's pharmaceutical specificity and the general medical supply and broad-spectrum pharmaceutical procurements tagged under it suggests either systematic miscoding in state and local systems or use of the code as a catch-all for pharmaceutical and medical items generally. Firms pursuing state and local pharmaceutical supply contracts should verify actual scope language in each RFP or IFB rather than relying on UNSPSC classification alone.